Clinical Trial Update: Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on tofacitinib for glucocorticoid-resistant moderate-to-severe Thyroid Eye Disease; the study is currently active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Ophthalmopathy
• Graves Orbitopathy
• Thyroid Eye Disease

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Thyroid Eye Disease, TED, Graves Ophthalmopathy | Phase 2 | Status: ACTIVE_NOT_RECRUITING